Skip to main content
FinSpry Logo
FinSpry
NVS logo
NVS
(NYSE)
Novartis AG
$149.15-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Novartis (NVS) Stock Price & Financial Analysis

Novartis Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$148.95 - $150.58
52-Week High$170.46
52-Week Low$104.93
Open$149.01
Volume1.08M
Average Volume (3M)1.37M
Market Cap283.72B
Shares Outstanding1.92B
P/E Ratio (TTM)20.96
Forward P/E20.27
Price to Sales (P/S)5.01
Price to Book (P/B)7.37
EV/EBITDA14.38
Revenue (TTM)56.58B
Net Income (TTM)13.53B
Free Cash Flow (TTM)16.60B
EPS (TTM)$6.99
Profit Margin23.92%
Operating Margin30.43%
Return on Equity (ROE)35.14%
Debt to Equity1.17
50-Day MA$151.37
200-Day MA$138.58
52-Week Change33.30%
Annual Dividend$4.77
Dividend Yield3.20%
Payout Ratio68.29%
Last Dividend Ex-DateMar 11, 2026

Frequently Asked Questions About Novartis

What is the current stock price for NVS?

As of the latest trading session, NVS stock trades at $149.15. The 52-week range is $104.93–$170.46, with a day range of $148.94–$150.58.

What is the P/E ratio for NVS?

Novartis's trailing P/E ratio is 21.0, meaning investors pay $21.0 for every $1 of annual earnings. The forward P/E is 20.3, reflecting analyst expectations for future earnings. Novartis operates in the Healthcare sector.

Does NVS pay dividends?

Yes, Novartis pays a 3.20% annual dividend yield ($4.77 per share). The payout ratio is 68.3%. The last ex-dividend date was 2026-03-11.

What do analysts recommend for NVS?

Based on 1 analyst, the consensus for NVS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NVS?

Novartis's market capitalization is $285.77B, classifying it as a mega-cap company. Novartis operates in the Healthcare sector within the Drug Manufacturers - General industry.